Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 751 AL 765

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer

Bailly M, Destrieux C, Hommet C, Mondon K, Cottier JP, Beaufils E, Vierron E, Vercouillie J, Ibazizene M, Voisin T, Payoux P, Barré L, Camus V, Guilloteau D, Ribeiro MJ.

Biomed Res Int. 2015;2015:583931. doi: 10.1155/2015/583931. Epub 2015 Jun 17.

Treatment Options in Alzheimer´s Disease: The GABA Story

Solas M, Puerta E, Ramirez MJ.

Curr Pharm Des. 2015;21(34):4960-71. doi: 10.2174/1381612821666150914121149.

Neurogranin Levels in Cerebrospinal Fluid: A New Addition to the Alzheimer Disease Diagnostic Toolbox

Zetterberg H, Blennow K.

JAMA Neurol. 2015 Nov;72(11):1237-8. doi: 10.1001/jamaneurol.2015.2075.

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete C, Greco A, Pilotto A, Logroscino G.

Expert Opin Pharmacother. 2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21.

Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia

Ballard C, Sharp S, Corbett A.

JAMA. 2015 Sep 22-29;314(12):1233-5. doi: 10.1001/jama.2015.10215.

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial

Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J.

JAMA. 2015 Sep 22-29;314(12):1242-54. doi: 10.1001/jama.2015.10214.

Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study

Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, Hauenstein K, Klöppel S, Grothe MJ, Kasper E, Teipel SJ.

J Alzheimers Dis. 2015;48(1):197-204. doi: 10.3233/JAD-150063.

Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Matsunaga S, Kishi T, Annas P, Basun H, Hampel H, Iwata N.

J Alzheimers Dis. 2015;48(2):403-10. doi: 10.3233/JAD-150437.

A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis

Atwood CS, Bowen RL.

J Alzheimers Dis. 2015;47(1):33-47. doi: 10.3233/JAD-143210.

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, Soares H, Kaplita S, Luo F, Pachai C, Bracoud L, Mintun M, Grill JD, Marek K, Seibyl J, Cedarbaum JM, Albright C, Feldman HH, Berman RM.

JAMA Neurol. 2015 Nov;72(11):1324-33. doi: 10.1001/jamaneurol.2015.0607.

Genetics ignite focus on microglial inflammation in Alzheimer's disease

Malik M, Parikh I, Vasquez JB, Smith C, Tai L, Bu G, LaDu MJ, Fardo DW, Rebeck GW, Estus S.

Mol Neurodegener. 2015 Oct 5;10:52. doi: 10.1186/s13024-015-0048-1.

A case of donepezil-related torsades de pointes

Kitt J, Irons R, Al-Obaidi M, Missouris C.

BMJ Case Rep. 2015 Oct 5;2015:bcr2015211900. doi: 10.1136/bcr-2015-211900.

Protein structures in Alzheimer's disease: The basis for rationale therapeutic design

Montoliu-Gaya L, Villegas S.

Arch Biochem Biophys. 2015 Dec 15;588:1-14. doi: 10.1016/j.abb.2015.10.005. Epub 2015 Oct 22.

Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease

Taipale H, Vuorikari H, Tanskanen A, Koponen M, Tiihonen J, Kettunen R, Hartikainen S.

Drugs Aging. 2015 Nov;32(11):937-45. doi: 10.1007/s40266-015-0316-3.

Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases

Zhao Y, Wang C.

Biomed Res Int. 2015;2015:174050. doi: 10.1155/2015/174050. Epub 2015 Sep 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias